Pacer Advisors, Inc. Tcr2 Therapeutics Inc. Transaction History

Pacer Advisors, Inc.

  • $38.6 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021
SELL
$16.41 - $24.71 $44,389 - $66,840
-2,705 Closed
0 $0
Q1 2021

Apr 05, 2021
BUY
$20.38 - $34.07 $33,097 - $55,329
1,624 Added 150.23%
2,705 $60,000
Q4 2020

Jan 20, 2021
BUY
$19.0 - $32.63 $20,539 - $35,273
1,081 New
1,081 $33,000

About TCR2 THERAPEUTICS INC.

TCRR Quotes by TradingView
  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email